Clinical Trials Logo

Clinical Trial Summary

The aim of the present study was to evaluate the effect of a phytotherapy agent on clinical and inflammatory parameters, for the postoperative therapy of the impacted third molar surgery. The null hypothesis to invalidate was that, after the last follow-up, there were no variations between the phytotherapy agent and the placebo.


Clinical Trial Description

The inclusion criteria were: (1) age between 18 and 32 years; (2) good general health; (3) the presence of two asymptomatic mandibular third molars with Class II position, type B impaction (Pell and Gregory, 1933), with similar root formation characteristics and position between the two sides; (4) absence of pericoronitis or signs of inflammation during the last 30 days. Orthopantomography (OPT) was used to determine tooth position. The exclusion criteria were (1) any systemic condition which might affect the study; (2) taking medications; (3) use of hormonal contraceptives; (4) medication by anti-inflammatory and immunosuppressive drugs; (5) status of pregnancy or lactation; (6) previous history of excessive drinking; (7) allergy to local anesthetic; (8) smoking.

The study was performed according to the CONSORT (Consolidated Standards Of Reporting Trials) guidelines. Patients who did not attend the second surgery or were unable to follow the study protocol were excluded, as were those whose surgical time exceeded 40 minutes.

Patients were scheduled for surgery in two separate clinical sessions (one side at a time), with a 1-month interval. Subjects were allocated to one of two groups according to the medication received 1 h and 12 h after surgery: group 1, Lenidase® (Enfarma SRL, Misterbianco, Italy); group 2, placebo (Sugar pill, Sucratol - Placebo Capsules). All patients in the study routinely received a prophylactic preoperative dose of oral antibiotic (1 g amoxicillin/clavulanic acid 1 hour before surgery) (Augmentin; GlaxoSmithKline, Verona, Italy). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03335683
Study type Interventional
Source University of Messina
Contact
Status Completed
Phase Phase 4
Start date January 7, 2016
Completion date June 30, 2017

See also
  Status Clinical Trial Phase
Completed NCT04918563 - Endothelium Dependent and Non-dependent Vasodilatation in Human Gingiva N/A
Active, not recruiting NCT06454084 - Investigation of Endothelium-dependent Vasodilation in Human Gingiva N/A
Completed NCT06238154 - Flurbiprofen Tablet vs Spray In Oral Soft Tissue Wounds Phase 4
Not yet recruiting NCT03717389 - The Prevalence of Soft Tissue Calcifications in the Head and Neck Region Using CBCT Among Egyptian Population
Completed NCT04131283 - Evidence of Spreading Vasoconstriction in Human Gingiva N/A
Not yet recruiting NCT06052501 - 3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations
Completed NCT03605095 - Evidence of Spreading Vasodilation in Human Gingiva N/A
Completed NCT02513368 - Peri Implant Soft Tissue Healing in Single Implant Restoration Using Two Different Techniques Phase 2
Recruiting NCT06029322 - Collagen Matrix Versus Collagen Membrane as Socket Seal in ARP N/A
Completed NCT04276129 - Early Healing of Oral Soft Tissues: a Clinical and Biomolecular Analysis. Part II N/A
Completed NCT04865952 - Early Healing of Oral Soft Tissues: a Clinical and Biomolecular Analysis. Part III N/A
Completed NCT04202822 - Early Healing of Oral Soft Tissues: a Clinical and Biomolecular Analysis. Part I N/A